跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目6401-6425 / 13672. (共547頁) << < 252 253 254 255 256 257 258 259 260 261 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2019-07	IGF1 gene is associated with triglyceride levels in subjects with family history of hypertension from the SAPPHIRe and TWB projects	European Journal of Human Genetics. 2019 Jul;27:163.
2006-04	IGFBP-3 suppresses tumor invasion through down regulation of ERK mitogen-activated protein kinases in ovarian endometrioid carcinoma	Cancer Research. 2006 Apr;66(8, Suppl.):71.
2013-07-23	IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder	Journal of Clinical Pathology. 2013 Jul 23;66(7):573-582.
2021-02	IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NF kappa B/IL-6/ROS signaling	Cancer Science. 2021 Feb;112(Suppl. 1):776.
2024-03	IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NFkappaB/IL-6/ROS signaling	Cancer Science. 2024 Mar;115(Suppl. 1):1429.
2015-04-15	IKKbeta enforces a LIN28B/TCF7L2 positive feedback loop that promotes cancer cell stemness and metastasis	Cancer Research. 2015 Apr 15;75(8):1725-1735.
2011-04	IL-10 promoter genetic polymorphisms and risk of Kawasaki disease in Taiwan	Disease Markers. 2011 Apr;30(1):51-59.
2024-11-26	IL-10RA governor the expression of IDO in the instruction of lymphocyte immunity	British Journal of Cancer. 2024 Nov 26;Article in Press.
2017-05	Il-17f induces Il-6 Via tak1-Nf kappaB pathway in airway smooth muscle cells	American Journal of Respiratory and Critical Care Medicine. 2017 May;195:A5302.
2017-06	IL-17F induces IL-6 via TAK1-NFkappaB pathway in airway smooth muscle cells	Immunity, Inflammation and Disease. 2017 Jun;5(2):124-131.
2016-01	IL-18-induced interaction between IMP3 and HuR contributes to COX-2 mRNA stabilization in acute myeloid leukemia	Journal of Leukocyte Biology. 2016 Jan;99(1):131-141.
2016-11	IL-1b mediates anti-progression activities in renal cell carcinoma by inducing MCP-1	Annals of Oncology. 2016 Nov;27(Suppl. 8):Meeting Abstract 35P.
2016-12	IL-1beta mediates anti-progression activities in renal cell carcinoma by inducing MCP-1	Annals of Oncology. 2016 Dec;27(Suppl. 9):Meeting Abstract 558P.
2015-04	IL-1beta promotes malignant transformation and tumor aggressiveness in oral cancer	Journal of Cellular Physiology. 2015 APR;230(4):875-884.
2020-12	IL-33: A key player in the development of iron-recycling red pulp macrophages	Cellular and Molecular Immunology. 2020 Dec;17(12):1218-1219.
2003-11-01	IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B	Journal of Immunology. 2003 Nov;171(9):4708-4716.
2005-09	IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells	American Journal of Physiology-Lung Cellular and Molecular Physiology. 2005 Sep;289(3):L446-L453.
2010-06	IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth	Immunobiology. 2010 Jun;215(6):486-491.
2016-06	IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma	Molecular Oncology. 2016 Jun;10(6):895-909.
2015-06	IL-9 induces IL-8 production via STIM1 activation and ERK phosphorylation in epidermal keratinocytes: A plausible mechanism of IL-9R in atopic dermatitis	Journal of Dermatological Science. 2015 Jun;78(3):206-214.
2015-05	IL-9/IL-9R of epidermal keratinocytes in atopic dermatitis: IL-9 induces IL-8 production through STIM1 activation and ERK phosphorylation	Journal of Investigative Dermatology. 2015 May;135(Suppl. 1):S90.
2024-07-01	Illicit drug use in adolescents versus adults among those with use of other psychoactive substance or depressive symptoms: A conditional prevalence analysis of the 2014 and 2018 national survey of substance use in Taiwan	Drug and Alcohol Dependence. 2024 Jul 01;260(Suppl.):Meeting Abstract 110748.
2023-11	ILLUMINATE: Efficacy and safety of durvalumab-tremelimumab and chemotherapy in EGFR mutant NSCLC following progression on EGFR inhibitors	Journal of Thoracic Oncology. 2023 Nov;18(11, Suppl.):S63.
2023-06-02	Illuminating and radiosensitizing tumors with 2DG-bound gold-based nanomedicine for targeted CT imaging and therapy	Nanomaterials. 2023 Jun 02;13(11):Article number 1790.
2023-07	Image collection and annotation platforms to establish a multi-source database of oral lesions	Oral Diseases. 2023 Jul;29(5):2230-2238.

顯示項目6401-6425 / 13672. (共547頁) << < 252 253 254 255 256 257 258 259 260 261 > >> 每頁顯示[10|25|50]項目